Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications

Conclusion: These results demonstrate that MM/RAPNPs could efficiently and safely inhibit the progression of AS. These biomimetic nanoparticles may be potential drug delivery systems for safe and effective anti-AS applications.

Source: Theranostics - January 15, 2021 Category: Molecular Biology Authors: Yi Wang, Kang Zhang, Tianhan Li, Ali Maruf, Xian Qin, Li Luo, Yuan Zhong, Juhui Qiu, Sean McGinty, Giuseppe Pontrelli, Xiaoling Liao, Wei Wu, Guixue Wang Tags: Research Paper Source Type: research